PERSPECTIVE THERAPEUTICS, INC. Operating Cash Flow
PERSPECTIVE THERAPEUTICS, INC. (CATX) reported Operating Cash Flow of -$52.12 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-10
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$20.65M.
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$31.47M.
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$24.66M.
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$16.29M, a 584.02% decline year-over-year.
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$82.48M.
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$18.29M.
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$36.91M.
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$10.40M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$20.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$52.12M 10-Q · filed 2026-08-10 | -$76.78M derived: sum of 3 quarters · filed 2026-08-10 | -$93.07M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2026-03-31 | -$31.47M 10-Q · filed 2026-05-11 | -$56.13M derived: sum of 2 quarters · filed 2026-05-11 | -$72.42M derived: sum of 3 quarters · filed 2026-05-11 | -$92.37M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-12-31 | -$24.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$40.95M derived: sum of 2 quarters · filed 2026-03-16 | -$60.90M derived: sum of 3 quarters · filed 2026-08-10 | -$82.48M 10-K · filed 2026-03-16 | |
| 2025-09-30 | -$16.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$36.24M derived: sum of 2 quarters · filed 2026-08-10 | -$57.83M 10-Q · filed 2025-11-10 | -$84.43M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-06-30 | -$19.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$41.53M 10-Q · filed 2026-08-10 | -$68.14M derived: sum of 3 quarters · filed 2026-08-10 | -$64.78M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-03-31 | -$21.58M 10-Q · filed 2026-05-11 | -$48.19M derived: sum of 2 quarters · filed 2026-05-11 | -$44.82M derived: sum of 3 quarters · filed 2026-05-11 | -$53.72M derived: sum of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | -$26.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$23.24M derived: sum of 2 quarters · filed 2026-03-16 | -$32.14M derived: sum of 3 quarters · filed 2026-03-16 | -$18.29M 10-K · filed 2026-03-16 | |
| 2024-09-30 | $3.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$5.54M derived: sum of 2 quarters · filed 2025-11-10 | $8.31M 10-Q · filed 2025-11-10 | -$696.00K derived: sum of 4 quarters · filed 2025-11-10 | |
| 2024-06-30 | -$8.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $4.95M 10-Q · filed 2025-08-13 | -$4.06M derived: sum of 3 quarters · filed 2025-08-13 | -$14.17M derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | $13.85M 10-Q · filed 2025-05-12 | $4.84M derived: sum of 2 quarters · filed 2025-05-12 | -$5.27M derived: sum of 3 quarters · filed 2025-05-12 | -$13.34M derived: sum of 4 quarters · filed 2025-05-12 | |
| 2023-12-31 | -$9.01M derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-03-28 | -$19.12M derived: sum of 2 quarters · filed 2025-03-28 | -$27.19M derived: sum of 3 quarters · filed 2025-03-28 | -$36.91M 10-K/A · filed 2025-03-28 | |
| 2023-09-30 | -$10.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$18.18M derived: sum of 2 quarters · filed 2024-11-12 | -$27.91M 10-Q · filed 2024-11-12 | -$32.23M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | -$8.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$17.80M 10-Q · filed 2024-08-13 | -$22.12M derived: sum of 3 quarters · filed 2024-08-13 | -$23.88M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | -$9.72M 10-Q · filed 2024-05-15 | -$14.05M derived: sum of 2 quarters · filed 2024-05-15 | -$15.81M derived: sum of 3 quarters · filed 2024-05-15 | -$18.70M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | -$4.32M derived: 10-K 6 month − 10-Q 3 month · filed 2024-03-28 | -$6.09M 10-K · filed 2024-03-28 | -$8.98M derived: sum of 3 quarters · filed 2024-03-28 | -$10.40M 10-K · filed 2024-03-28 | |
| 2022-09-30 | -$1.76M 10-Q · filed 2022-11-14 | -$4.65M derived: sum of 2 quarters · filed 2023-08-11 | -$6.08M 10-Q · filed 2023-11-14 | -$7.39M derived: sum of 4 quarters · filed 2023-08-11 | |
| 2022-06-30 | -$2.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$4.32M 10-Q · filed 2023-08-11 | -$5.63M derived: sum of 3 quarters · filed 2023-08-11 | -$7.71M 10-K · filed 2024-03-28 | |
| 2022-03-31 | -$1.42M 10-Q · filed 2023-05-15 | -$2.73M derived: sum of 2 quarters · filed 2023-05-15 | -$4.82M 10-Q · filed 2022-05-13 | -$5.94M derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | -$1.31M derived: 10-KT 6 month − 10-Q 3 month · filed 2023-05-01 | -$3.40M 10-KT · filed 2023-05-01 | -$3.40M 10-Q · filed 2022-02-09 | -$4.51M derived: sum of 3 quarters · filed 2023-05-01 | -$5.13M derived: sum of 4 quarters · filed 2023-05-01 |
| 2021-09-30 | -$2.08M 10-Q · filed 2022-11-14 | -$3.20M derived: sum of 2 quarters · filed 2023-05-01 | -$3.82M derived: sum of 3 quarters · filed 2023-05-01 | -$4.58M derived: sum of 4 quarters · filed 2023-05-01 | |
| 2021-06-30 | -$1.12M derived: 10-KT 12 month − 10-Q 9 month · filed 2023-05-01 | -$1.74M derived: sum of 2 quarters · filed 2023-05-01 | -$2.50M derived: sum of 3 quarters · filed 2023-05-01 | -$2.84M 10-KT · filed 2023-05-01 | |
| 2021-03-31 | -$621.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-13 | -$1.38M derived: sum of 2 quarters · filed 2022-05-13 | -$1.72M 10-Q · filed 2022-05-13 | -$2.57M derived: sum of 4 quarters · filed 2023-05-01 | |
| 2020-12-31 | -$760.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-09 | -$1.10M 10-Q · filed 2022-02-09 | -$1.95M derived: sum of 3 quarters · filed 2023-05-01 | -$2.81M derived: sum of 4 quarters · filed 2023-05-01 | |
| 2020-09-30 | -$338.00K 10-Q · filed 2021-11-10 | -$1.19M derived: sum of 2 quarters · filed 2023-05-01 | -$2.05M derived: sum of 3 quarters · filed 2023-05-01 | -$3.33M derived: sum of 4 quarters · filed 2023-05-01 | |
| 2020-06-30 | -$848.00K derived: 10-KT 12 month − 10-Q 9 month · filed 2023-05-01 | -$1.71M derived: sum of 2 quarters · filed 2023-05-01 | -$2.99M derived: sum of 3 quarters · filed 2023-05-01 | -$3.64M 10-KT · filed 2023-05-01 | |
| 2020-03-31 | -$862.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-14 | -$2.14M derived: sum of 2 quarters · filed 2021-05-14 | -$2.79M 10-Q · filed 2021-05-14 | -$3.78M derived: sum of 4 quarters · filed 2021-09-27 | |
| 2019-12-31 | -$1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-09 | -$1.93M 10-Q · filed 2021-02-09 | -$2.92M derived: sum of 3 quarters · filed 2021-09-27 | -$4.25M derived: sum of 4 quarters · filed 2021-09-27 | |
| 2019-09-30 | -$653.00K 10-Q · filed 2020-11-13 | -$1.64M derived: sum of 2 quarters · filed 2021-09-27 | -$2.98M derived: sum of 3 quarters · filed 2021-09-27 | -$4.09M derived: sum of 4 quarters · filed 2021-09-27 | |
| 2019-06-30 | -$985.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-27 | -$2.32M derived: sum of 2 quarters · filed 2021-09-27 | -$3.44M derived: sum of 3 quarters · filed 2021-09-27 | -$5.05M 10-K · filed 2021-09-27 | |
| 2019-03-31 | -$1.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-13 | -$2.45M derived: sum of 2 quarters · filed 2020-05-13 | -$4.06M 10-Q · filed 2020-05-13 | -$5.51M derived: sum of 4 quarters · filed 2020-09-25 | |
| 2018-12-31 | -$1.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-12 | -$2.73M 10-Q · filed 2020-02-12 | -$4.17M derived: sum of 3 quarters · filed 2020-09-25 | -$5.25M derived: sum of 4 quarters · filed 2020-09-25 | |
| 2018-09-30 | -$1.61M 10-Q · filed 2019-11-13 | -$3.06M derived: sum of 2 quarters · filed 2020-09-25 | -$4.14M derived: sum of 3 quarters · filed 2020-09-25 | -$5.66M derived: sum of 4 quarters · filed 2020-09-25 | |
| 2018-06-30 | -$1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-25 | -$2.53M derived: sum of 2 quarters · filed 2020-09-25 | -$4.05M derived: sum of 3 quarters · filed 2020-09-25 | -$5.71M 10-K · filed 2020-09-25 | |
| 2018-03-31 | -$1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-10 | -$2.60M derived: sum of 2 quarters · filed 2019-05-10 | -$4.26M 10-Q · filed 2019-05-10 | -$5.48M derived: sum of 4 quarters · filed 2019-09-27 | |
| 2017-12-31 | -$1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-13 | -$3.18M 10-Q · filed 2019-02-13 | -$4.40M derived: sum of 3 quarters · filed 2019-09-27 | -$5.88M derived: sum of 4 quarters · filed 2019-09-27 | |
| 2017-09-30 | -$1.66M 10-Q · filed 2018-11-09 | -$2.87M derived: sum of 2 quarters · filed 2019-09-27 | -$4.36M derived: sum of 3 quarters · filed 2019-09-27 | -$6.02M derived: sum of 4 quarters · filed 2019-09-27 | |
| 2017-06-30 | -$1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-27 | -$2.70M derived: sum of 2 quarters · filed 2019-09-27 | -$4.36M derived: sum of 3 quarters · filed 2019-09-27 | -$5.71M 10-K · filed 2019-09-27 | |
| 2017-03-31 | -$1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-04 | -$3.15M derived: sum of 2 quarters · filed 2018-05-04 | -$4.50M 10-Q · filed 2018-05-04 | ||
| 2016-12-31 | -$1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-09 | -$3.01M 10-Q · filed 2018-02-09 | |||
| 2016-09-30 | -$1.35M 10-Q · filed 2017-11-14 | ||||
| 2016-06-30 | -$3.88M 10-K · filed 2018-09-26 | ||||
| 2013-09-30 | -$892.02K 10-Q · filed 2013-11-14 | -$1.68M derived: sum of 2 quarters · filed 2013-11-14 | -$2.44M derived: sum of 3 quarters · filed 2013-11-14 | -$3.01M derived: sum of 4 quarters · filed 2013-11-14 | |
| 2013-06-30 | -$786.32K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-30 | -$1.54M derived: sum of 2 quarters · filed 2013-09-30 | -$2.12M derived: sum of 3 quarters · filed 2013-09-30 | -$3.06M 10-K · filed 2013-09-30 | |
| 2013-03-31 | -$756.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-15 | -$1.33M derived: sum of 2 quarters · filed 2013-05-15 | -$2.27M 10-Q · filed 2013-05-15 | -$2.89M derived: sum of 4 quarters · filed 2013-11-14 | |
| 2012-12-31 | -$574.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-14 | -$1.51M 10-Q · filed 2013-02-14 | -$2.14M derived: sum of 3 quarters · filed 2013-11-14 | -$2.95M derived: sum of 4 quarters · filed 2013-11-14 | |
| 2012-09-30 | -$938.63K 10-Q · filed 2013-11-14 | -$1.56M derived: sum of 2 quarters · filed 2013-11-14 | -$2.37M derived: sum of 3 quarters · filed 2013-11-14 | -$2.84M derived: sum of 4 quarters · filed 2013-11-14 | |
| 2012-06-30 | -$623.56K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-30 | -$1.43M derived: sum of 2 quarters · filed 2013-09-30 | -$1.91M derived: sum of 3 quarters · filed 2013-09-30 | -$2.45M 10-K · filed 2013-09-30 | |
| 2012-03-31 | -$810.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-15 | -$1.28M derived: sum of 2 quarters · filed 2013-05-15 | -$1.82M 10-Q · filed 2013-05-15 | -$2.43M derived: sum of 4 quarters · filed 2013-05-15 | |
| 2011-12-31 | -$472.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-14 | -$1.01M 10-Q · filed 2013-02-14 | -$1.62M derived: sum of 3 quarters · filed 2013-02-14 | -$2.15M derived: sum of 4 quarters · filed 2013-02-14 | |
| 2011-09-30 | -$542.09K 10-Q · filed 2012-11-14 | -$1.15M derived: sum of 2 quarters · filed 2012-11-14 | -$1.67M derived: sum of 3 quarters · filed 2012-11-14 | -$2.32M derived: sum of 4 quarters · filed 2012-11-14 | |
| 2011-06-30 | -$610.54K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-10-26 | -$1.13M derived: sum of 2 quarters · filed 2012-10-26 | -$1.78M derived: sum of 3 quarters · filed 2012-10-26 | -$2.42M 10-K/A · filed 2012-10-26 | |
| 2011-03-31 | -$520.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-15 | -$1.17M derived: sum of 2 quarters · filed 2012-05-15 | -$1.81M 10-Q · filed 2012-05-15 | ||
| 2010-12-31 | -$647.38K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2012-02-14 | -$1.29M 10-Q · filed 2012-02-14 | |||
| 2010-09-30 | -$640.27K 10-Q/A · filed 2011-12-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |